| Original language | English |
|---|---|
| Title of host publication | Case reports of CSU patients treated with omalizumab. |
| Publication date | 2017 |
| Pages | 38-9 |
| Commissioning body | Novartis Pharma AG |
| Publication status | Published - 2017 |
| Original language | English |
|---|---|
| Title of host publication | Case reports of CSU patients treated with omalizumab. |
| Publication date | 2017 |
| Pages | 38-9 |
| Commissioning body | Novartis Pharma AG |
| Publication status | Published - 2017 |